Search

Your search keyword '"Andrés Moret"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Andrés Moret" Remove constraint Author: "Andrés Moret"
26 results on '"Andrés Moret"'

Search Results

1. Unraveling the effect of silent, intronic and missense mutations on VWF splicing: contribution of next generation sequencing in the study of mRNA

2. Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project.

3. Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients

4. Factor XIII deficiency in two Spanish families with a novel variant in gene F13A1 detected by next-generation sequencing; symptoms and clinical management

5. Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort

6. Next generation sequencing in bleeding disorders: two novel variants in the F5 gene (Valencia-1 and Valencia-2) associated with mild factor V deficiency

7. Clinical and molecular characterization by next generation sequencing of Spanish patients affected by congenital deficiencies of fibrinogen

8. Involvement of antifactor VIII autoantibodies specificity in the outcome of inhibitor eradication therapies in acquired hemophilia a patients

9. Is on-demand treatment effective in patients with severe haemophilia?

10. Guía práctica de tratamiento urgente de la microangiopatía trombótica

11. Practice guidelines for the emergency treatment of thrombotic microangiopathy

12. Molecular and clinical profile of von willebrand disease in spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm

13. Inhibitors in haemophilia A: current management and open issues

14. Diagnosis and management of von willebrand disease in Spain

15. Home‐delivered ultrasound monitoring for home treatment of haemarthrosis in haemophilia A

16. Quality of thawed plasma inactivated with methylene blue after 48-hour storage

17. First application of MLPA method in severe von Willebrand disease. Confirmation of a new large VWF gene deletion and identification of heterozygous carriers

18. Inhibitor development after switching of FVIII concentrate in multitransfused patients with severe haemophilia A

19. Secondary prophylaxis vs. on-demand treatment to improve quality of life in severe adult haemophilia A patients: a prospective study in a single centre

20. Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method

21. Head-to-head comparison of the pharmacokinetic profiles of a high-purity factor IX concentrate (AlphaNine®) and a recombinant factor IX (BeneFIX®) in patients with severe haemophilia B

24. Novel missense mutation c.2685GC (p.Q895H) in VWF gene associated with very low levels of VWF mRNA

25. One-stage and chromogenic FVIII:C assay discrepancy in mild haemophilia A and the relationship with the mutation and bleeding phenotype

26. C0123: Combined Deficiency of Protein C, Protein S and Antithrombin in Patients with Mesenteric or Portal Venous Thrombosis with or without Hepatic Cirrhosis

Catalog

Books, media, physical & digital resources